Gossamer Bio Inc reports results for the quarter ended in September - Earnings Summary

Gossamer Bio

07/11/2022 12:01

* Gossamer Bio Inc  GOSS.OQ  reported a quarterly adjusted
loss
of 65 cents​​ per share for the quarter ended in September. The
mean expectation of twelve analysts for the quarter was for a
loss of 64 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Gossamer Bio Inc's reported EPS for the quarter was a loss
of 65
cents​.
    * The mean earnings estimate of analysts had risen by
about 0.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Gossamer Bio Inc shares had fallen by 12.2% this
quarter and
lost 7.0% so far this year.
    * The company reported a quarterly loss of $59.36 million.
    * Wall Street's median 12-month price target for Gossamer
Bio Inc
is $18.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
7 at 12:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.64          -0.65          Missed
 Jun. 30 2022      -0.70          -0.74          Missed
 Mar. 31 2022      -0.77          -0.76          Beat
 Dec. 31 2021      -0.74          -0.74          Met